Origin and function of myofibroblasts in the liver

Seminars in Liver Disease

Volumn 35, Issue 2, 2015, Pages 97-106

  Wells, Rebecca G ^a   Schwabe, Robert ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

fibrocyte; hepatic stellate cell; portal fibroblast

Indexed keywords

ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL FUNCTION; CELL POPULATION; CELL SPECIFICITY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; FIBROBLAST; HYPOTHESIS; LIVER FIBROSIS; MESENCHYMAL STEM CELL; MESOTHELIUM CELL; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION; STELLATE CELL; CELL PROLIFERATION; HUMAN; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

CELL PROLIFERATION; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER CIRRHOSIS; MYOFIBROBLASTS;

EID: 84929320584     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0035-1550061     Document Type: Article

References (85)

1. Tomasek J. J., Gabbiani G., Hinz B., Chaponnier C., Brown R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol: 2002; 3 5 349 363
2. Hinz B., Phan S. H., Thannickal V. J., Galli A., Bochaton-Piallat M. L., Gabbiani G. The myofibroblast: one function, multiple origins. Am J Pathol: 2007; 170 6 1807 1816
3. Thiery J. P., Acloque H., Huang R. Y., Nieto M. A. Epithelial-mesenchymal transitions in development and disease. Cell: 2009; 139 5 871 890
4. Scholten D., Osterreicher C. H., Scholten A., et al. Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice. Gastroenterology: 2010; 139 3 987 998
5. Taura K., Miura K., Iwaisako K., et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology: 2010; 51 3 1027 1036
6. Chu A. S., Diaz R., Hui J. J., et al. Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology: 2011; 53 5 1685 1695
7. Mederacke I., Hsu C. C., Troeger J. S., et al. Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. Nat Commun: 2013; 4 2823
8. Wynn T. A., Ramalingam T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med: 2012; 18 7 1028 1040
9. Kupffer K. Uber Sternzellen der Leber. Briefliche Mitteilung an Professor Waldeyer. Arch Mikr Anat: 1876; 12 353 358
10. Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis: 2001; 21 3 311 335
11. Friedman S. L. Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev: 2008; 88 1 125 172
12. Friedman S. L., Roll F. J., Boyles J., Bissell D. M. Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc Natl Acad Sci U S A: 1985; 82 24 8681 8685
13. Wake K. "Sternzellen" in the liver: perisinusoidal cells with special reference to storage of vitamin A. Am J Anat: 1971; 132 4 429 462
14. Knook D. L., Seffelaar A. M., de Leeuw A. M. Fat-storing cells of the rat liver. Their isolation and purification. Exp Cell Res: 1982; 139 2 468 471
15. Geerts A., Niki T., Hellemans K., et al. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology: 1998; 27 2 590 598
16. Mederacke I., Dapito D. H., Affo S., Uchinami H., Schwabe R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat Protoc: 2015; 10 2 305 315
17. Kluwe J., Wongsiriroj N., Troeger J. S., et al. Absence of hepatic stellate cell retinoid lipid droplets does not enhance hepatic fibrosis but decreases hepatic carcinogenesis. Gut: 2011; 60 9 1260 1268
18. Henderson N. C., Arnold T. D., Katamura Y., et al. Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med: 2013; 19 12 1617 1624
19. Yin C., Evason K. J., Maher J. J., Stainier D. Y. The basic helix-loop-helix transcription factor, heart and neural crest derivatives expressed transcript 2, marks hepatic stellate cells in zebrafish: analysis of stellate cell entry into the developing liver. Hepatology: 2012; 56 5 1958 1970
20. Oesterreicher C. H., Lemberger U. J., Mahon R., Rülicke T., Trauner M., Casanova E. Hepatic stellate cells are the major source of collagen in murine models of liver fibrosis. J Hepatol: 2014; 60 S61
21. Iwaisako K., Jiang C., Zhang M., et al. Origin of myofibroblasts in the fibrotic liver in mice. Proc Natl Acad Sci U S A: 2014; 111 32 E3297 E3305
22. Troeger J. S., Mederacke I., Gwak G. Y., et al. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice. Gastroenterology: 2012; 143 4 1073 83.e22
23. Seki E., Schwabe R. F. Hepatic inflammation and fibrosis: functional links and key pathways. Hepatology: 2015; 61 3 1066 1079
24. Luedde T., Kaplowitz N., Schwabe R. F. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology: 2014; 147 4 765 783.e4
25. Wells R. G. Tissue mechanics and fibrosis. Biochim Biophys Acta: 2013; 1832 7 884 890
26. Perepelyuk M., Terajima M., Wang A. Y., et al. Hepatic stellate cells and portal fibroblasts are the major cellular sources of collagens and lysyl oxidases in normal liver and early after injury. Am J Physiol Gastrointest Liver Physiol: 2013; 304 6 G605 G614
27. Canbay A., Taimr P., Torok N., Higuchi H., Friedman S., Gores G. J. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab Invest: 2003; 83 5 655 663
28. Zhan S. S., Jiang J. X., Wu J., et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology: 2006; 43 3 435 443
29. Iredale J. P., Benyon R. C., Pickering J., et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest: 1998; 102 3 538 549
30. Elsharkawy A. M., Mann D. A. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis. Hepatology: 2007; 46 2 590 597
31. Luedde T., Schwabe R. F. NF-κB in the liver-linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol: 2011; 8 2 108 118
32. Pradere J. P., Kluwe J., De Minicis S., et al. Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology: 2013; 58 4 1461 1473
33. Kisseleva T., Cong M., Paik Y., et al. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis. Proc Natl Acad Sci U S A: 2012; 109 24 9448 9453
34. McHedlidze T., Waldner M., Zopf S., et al. Interleukin-33-dependent innate lymphoid cells mediate hepatic fibrosis. Immunity: 2013; 39 2 357 371
35. Dranoff J. A., Wells R. G. Portal fibroblasts: Underappreciated mediators of biliary fibrosis. Hepatology: 2010; 51 4 1438 1444
36. Carruthers J. S., Kalifat S. R., Steiner J. W. The ductular cell reaction of rat liver in extrahepatic cholestasis. II. The proliferation of connective tissue. Exp Mol Pathol: 1962; 1 377 396
37. Li Z., Dranoff J. A., Chan E. P., Uemura M., Sévigny J., Wells R. G. Transforming growth factor-beta and substrate stiffness regulate portal fibroblast activation in culture. Hepatology: 2007; 46 4 1246 1256
38. Kinnman N., Francoz C., Barbu V., et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest: 2003; 83 2 163 173
39. Lemoinne S., Cadoret A., Rautou P. E., et al. Portal myofibroblasts promote vascular remodeling underlying cirrhosis formation through the release of microparticles. Hepatology: 2015; 61 3 1041 1055
40. Kruglov E. A., Jain D., Dranoff J. A. Isolation of primary rat liver fibroblasts. J Investig Med: 2002; 50 3 179 184
41. Knittel T., Kobold D., Saile B., et al. Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential. Gastroenterology: 1999; 117 5 1205 1221
42. Chang K., Pastan I. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers. Proc Natl Acad Sci U S A: 1996; 93 1 136 140
43. Olsen A. L., Bloomer S. A., Chan E. P., et al. Hepatic stellate cells require a stiff environment for myofibroblastic differentiation. Am J Physiol Gastrointest Liver Physiol: 2011; 301 1 G110 G118
44. Clouzeau-Girard H., Guyot C., Combe C., et al. Effects of bile acids on biliary epithelial cell proliferation and portal fibroblast activation using rat liver slices. Lab Invest: 2006; 86 3 275 285
45. Borkham-Kamphorst E., Schaffrath C., Van de Leur E., et al. The anti-fibrotic effects of CCN1/CYR61 in primary portal myofibroblasts are mediated through induction of reactive oxygen species resulting in cellular senescence, apoptosis and attenuated TGF-β signaling. Biochim Biophys Acta: 2014; 1843 5 902 914
46. Kinnman N., Housset C. Peribiliary myofibroblasts in biliary type liver fibrosis. Front Biosci: 2002; 7 d496 d503
47. Guyot C., Combe C., Desmoulière A. The common bile duct ligation in rat: A relevant in vivo model to study the role of mechanical stress on cell and matrix behaviour. Histochem Cell Biol: 2006; 126 4 517 523
48. Kameyama A., Hatayama H., Kato J., et al. Light-curing of dental resins with GaN violet laser diode: the effect of photoinitiator on mechanical strength. Lasers Med Sci: 2011; 26 3 279 283
49. Omenetti A., Yang L., Li Y. X., et al. Hedgehog-mediated mesenchymal-epithelial interactions modulate hepatic response to bile duct ligation. Lab Invest: 2007; 87 5 499 514
50. Van Hul N. K., Abarca-Quinones J., Sempoux C., Horsmans Y., Leclercq I. A. Relation between liver progenitor cell expansion and extracellular matrix deposition in a CDE-induced murine model of chronic liver injury. Hepatology: 2009; 49 5 1625 1635
51. Wells R. G., Kruglov E., Dranoff J. A. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth. FEBS Lett: 2004; 559 1-3 107 110
52. Wells R. G. The portal fibroblast: not just a poor man's stellate cell. Gastroenterology: 2014; 147 1 41 47
53. Jhandier M. N., Kruglov E. A., Lavoie E. G., Sévigny J., Dranoff J. A. Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem: 2005; 280 24 22986 22992
54. Sirica A. E. The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma. Nat Rev Gastroenterol Hepatol: 2012; 9 1 44 54
55. Russo F. P., Alison M. R., Bigger B. W., et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology: 2006; 130 6 1807 1821
56. Kisseleva T., Uchinami H., Feirt N., et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol: 2006; 45 3 429 438
57. Higashiyama R., Moro T., Nakao S., et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology: 2009; 137 4 1459 66.e1
58. Scholten D., Reichart D., Paik Y. H., et al. Migration of fibrocytes in fibrogenic liver injury. Am J Pathol: 2011; 179 1 189 198
59. Asahina K., Tsai S. Y., Li P., et al. Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology: 2009; 49 3 998 1011
60. Li Y., Wang J., Asahina K. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial-mesenchymal transition in liver injury. Proc Natl Acad Sci U S A: 2013; 110 6 2324 2329
61. Chapman G. B., Eagles D. A. Ultrastructural features of Glisson's capsule and the overlying mesothelium in rat, monkey and pike liver. Tissue Cell: 2007; 39 5 343 351
62. Bhunchet E., Wake K. Role of mesenchymal cell populations in porcine serum-induced rat liver fibrosis. Hepatology: 1992; 16 6 1452 1473
63. Asahina K., Zhou B., Pu W. T., Tsukamoto H. Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver. Hepatology: 2011; 53 3 983 995
64. Kramann R., Schneider R. K., DiRocco D. P., et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell: 2015; 16 1 51 66
65. Sicklick J. K., Li Y. X., Choi S. S., et al. Role for hedgehog signaling in hepatic stellate cell activation and viability. Lab Invest: 2005; 85 11 1368 1380
66. Lua I., James D., Wang J., Wang K. S., Asahina K. Mesodermal mesenchymal cells give rise to myofibroblasts, but not epithelial cells, in mouse liver injury. Hepatology: 2014; 60 1 311 322
67. Rowe R. G., Lin Y., Shimizu-Hirota R., et al. Hepatocyte-derived Snail1 propagates liver fibrosis progression. Mol Cell Biol: 2011; 31 12 2392 2403
68. Díaz R., Kim J. W., Hui J. J., et al. Evidence for the epithelial to mesenchymal transition in biliary atresia fibrosis. Hum Pathol: 2008; 39 1 102 115
69. Rygiel K. A., Robertson H., Marshall H. L., et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest: 2008; 88 2 112 123
70. Omenetti A., Porrello A., Jung Y., et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest: 2008; 118 10 3331 3342
71. Williams M. J., Clouston A. D., Forbes S. J. Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion. Gastroenterology: 2014; 146 2 349 356
72. Marra F., Pinzani M. Role of hepatic stellate cells in the pathogenesis of portal hypertension. Nefrologia: 2002; 22 05 34 40
73. Winau F., Quack C., Darmoise A., Kaufmann S. H. Starring stellate cells in liver immunology. Curr Opin Immunol: 2008; 20 1 68 74
74. Gabrielli G. B., Casaril M., Stanzial A. M., Colombari R., Pasino M., Corrocher R. Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon. Hepatogastroenterology: 2003; 50 54 2017 2021
75. Garcia-Tsao G., Friedman S., Iredale J., Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology: 2010; 51 4 1445 1449
76. Van Rossen E., Vander Borght S., van Grunsven L. A., et al. Vinculin and cellular retinol-binding protein-1 are markers for quiescent and activated hepatic stellate cells in formalin-fixed paraffin embedded human liver. Histochem Cell Biol: 2009; 131 3 313 325
77. Guido M., Rugge M., Leandro G., Fiel I. M., Thung S. N. Hepatic stellate cell immunodetection and cirrhotic evolution of viral hepatitis in liver allografts. Hepatology: 1997; 26 2 310 314
78. Carpino G., Morini S., Ginanni Corradini S., et al. Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation. Dig Liver Dis: 2005; 37 5 349 356
79. Akpolat N., Yahsi S., Godekmerdan A., Yalniz M., Demirbag K. The value of alpha-SMA in the evaluation of hepatic fibrosis severity in hepatitis B infection and cirrhosis development: a histopathological and immunohistochemical study. Histopathology: 2005; 47 3 276 280
80. Lau D. T., Luxon B. A., Xiao S. Y., Beard M. R., Lemon S. M. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology: 2005; 42 2 273 281
81. Khan M. A., Poulos J. E., Brunt E. M., et al. Hepatic alpha-smooth muscle actin expression in hepatitis C patients before and after interferon therapy. Hepatogastroenterology: 2001; 48 37 212 215
82. Kweon Y. O., Goodman Z. D., Dienstag J. L., et al. Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B. J Hepatol: 2001; 35 6 749 755
83. Schmitt-Gräff A., Krüger S., Bochard F., Gabbiani G., Denk H. Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol: 1991; 138 5 1233 1242
84. Magness S. T., Bataller R., Yang L., Brenner D. A. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology: 2004; 40 5 1151 1159
85. Bansal R., Prakash J., Post E., Beljaars L., Schuppan D., Poelstra K. Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology: 2011; 54 2 586 596